N.I.H. Director Will Temporarily Run C.D.C. in Leadership Shake-Up / NYT

Sheryl Gay Stolberg / nytimes - Dr. Jay Bhattacharya will serve as acting director of the Centers for Disease Control and Prevention until President Trump appoints a permanent director.

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety

CDC vaccine committee cancels meeting

24 days / beckershospitalreview / Erica Cerutti

Amid CDC upheaval, key vaccine panel won't convene February meeting

25 days / fiercehealthcare

NIH director named acting CDC chief amid leadership shake-ups

26 days / beckershospitalreview / Ella Jeffries

NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports

26 days / fiercehealthcare

N.I.H. Director Will Temporarily Run C.D.C. in Leadership Shake-Up

26 days / nytimes / Sheryl Gay Stolberg

Wednesday, February 18, 2026, 7:22 pm / permalink 19391 / 5 stories in 26 days

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine / NYT

Christina Jewett and Rebecca Robbins / nytimes - Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #vaccinesafety

Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more

23 days / endpoints / Max Gelman

FDA's abrupt flip-flop on Moderna's mRNA flu shot highlights growing risks to drug-makers of investing in vaccines

25 days / medicalxpress

What the Health? From KFF Health News: Turnarounds and Shake-Ups

25 days / kffhealthnews

Study shows low vaccination rates among expectant mothers in Norway against COVID-19, influenza

25 days / medicalxpress

FDA reverses course; agrees to review Moderna flu vaccine

26 days / beckershospitalreview / Erica Cerutti

Reversal on Moderna's flu application follows atypical path through FDA

26 days / endpoints / Zachary Brennan

Moderna says the FDA will consider its new flu shot after resolving a public dispute

26 days / abcnews

In reversal, US agrees to review new Moderna flu shot

26 days / medicalxpress

FDA reverses course on Moderna’s flu vaccine

26 days / healthcaredive / Delilah Alvarado

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

26 days / nytimes / Christina Jewett and Rebecca Robbins

FDA reverses course, will review Moderna’s flu vaccine

26 days / endpoints / Max Bayer

Wednesday, February 18, 2026, 9:23 am / permalink 19353 / 11 stories in 26 days

StackHealth Time Machine

Outgoing Stories

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 16.5 hours

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 17.5 hours

Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 19.5 hours

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 20.5 hours

FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 32.5 hours

HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 45.5 hours

Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 48.5 hours

Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 49.5 hours

Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 54.5 hours

AI improves UK breast-screening detection by about 10% 5 stories in 54.5 hours

More StackHealth

Bluesky: